Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Supplement-Related ER Diagnosis Prompts Industry Call For A Second Opinion

This article was originally published in The Tan Sheet

Executive Summary

An NEJM study, from research by a team including FDA dietary supplement program officials, concludes that 23,005 ER cases and 2,154 hospitalizations linked to supplements occur annually in the US. Trade group officials question the study’s data collection and methodology.


Related Content

Final Guidance For Reporting Adverse Events Gets Serious On Definitions





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts